United Kingdom · Biotechnology startup

COMPASS Pathways

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

Funding reportedLast round: Post ipo equity

BiotechnologyAltrincham, United Kingdom

What company datasets say COMPASS Pathways raised

Funding, as reported

Reported in all271.2Min the source's currency
Rounds6
Last roundPost ipo equity
Last round dateAug 2023
Investors listed24

Founders and team

From COMPASS Pathways's own website: 7 on the team.

  • Kabir NathChief Executive Officer
  • Dr. Guy GoodwinChief Medical Officer
  • Dr. Michael GoldChief Research & Development Officer
  • Dr. Steve LevineChief Patient Officer
  • Kelley BoucherChief People Officer
  • Lori EnglebertChief Commercial Officer
  • Teri LoxamChief Financial Officer

On 7 portfolio pages

Investors who name them

Each firm lists COMPASS Pathways on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in United Kingdom

Startups like it

Is this your company?

Add your raise, your deck and your story, and put COMPASS Pathways in front of investors. Or tell us what we have wrong.